Since proliferation was successfully inhibited in both cell lines by linsitinib, it appears that ERα(Ser167) phosphorylation might be a more relevant IGF‐1R‐dependent phosphorylation site on ER to drive tumor cell proliferation capacity than phosphorylation of ERα(Ser118). The gene discussed is IGF1R; the disease is neoplasm.